Oryon Cell Therapies
About
Technology stack
detected 2026-05-24No comments yet. Be the first to share your take.
What does Oryon Cell Therapies do?
Oryon Cell Therapies is a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders. The company has emerged from stealth and secured significant funding to advance its therapeutic programs.
How much funding has Oryon Cell Therapies raised?
Oryon Cell Therapies has raised a total of $21M in funding. The most recent round on record is Series A.
Where is Oryon Cell Therapies headquartered?
Oryon Cell Therapies is headquartered in Belmont, Massachusetts, USA.
What industry does Oryon Cell Therapies operate in?
Oryon Cell Therapies operates in Biotechnology, Health, Neuroscience, Cell Therapy.
What is Oryon Cell Therapies's current status?
Oryon Cell Therapies's current operating status is: Inactive.
What is Oryon Cell Therapies's revenue?
StartupHub estimates Oryon Cell Therapies's annual revenue at $2.7M (range $683K to $8.8M, 37% confidence), based on comparable companies in the sector.
What is Oryon Cell Therapies's valuation?
StartupHub estimates Oryon Cell Therapies's effective valuation at $89.0M (range $52.5M to $126.0M, 24% confidence), based on comparable companies in the sector.